Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi USD Fed Funds Rate UCITS ETF Dist
C101 · LU2090062352 · class UCITS ETF Dist · USD · domicile Luxembourg
Money market · USD · EurozoneSFDR art. 6
Index tracked: Solactive Fed Funds Effective Rate Total Return Index
- TER
- 0.10%+ trans. 0.00%
- Fund size
- 6 m EUR
- Tracking difference
- −0.12%3-year avg
- 🇮🇹 tax rate
- 19.24%white list 50.06%
- Replication
- Synthetic (swap)
- Income
- Distributingannual
Launch 6 Mar 2020 · costs from the KID as of 2 Sept 2026 · 257 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 8 Aug 2026
The Fund is an index-tracking UCITS passively managed. The investment objective is to reflect the performance of the Solactive Fed Funds Effective Rate Total Return index" ("Benchmark Index") denominated in USD, representative of the performance of a cash notional deposit paying the Federal Funds Effective Rate, which is the US short term reference rate for monetary market, with daily reinvestment of interests earned in the deposit. Additional information about the Benchmark Index can be found at www.solactive.com The Benchmark Index is a total return…
Performance since series start (in euro) — base 100
5 Mar 2020 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +4.5% |
| 3 years | +5.3% |
| 5 years | +22.6% |
| 10 years | series too young |
| Since series start | +15.6% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 4.33% | 4.67% | 3.61% |
| Max drawdown | −4.27% | −5.36% | −5.36% |
| Sharpe | -0.65 | -0.71 | -0.45 |
| Sortino | -0.65 | -0.71 | -0.46 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · C101 · LU20900623521
RebalixC101 · LU2090062352 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +4.23% | +4.39% | −0.16% |
| 2024 | +5.23% | +5.37% | −0.14% |
| 2023 | +5.13% | +5.21% | −0.07% |
| 2022 | +1.60% | +1.72% | −0.11% |
| 2021 | −0.03% | +0.08% | −0.11% |
Distributions · per share, in USD
Frequency: annual · last 12 months: 4.60 USD (4.35% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 4.60 | +4.45% |
| 2024 | 1 | 5.61 | +5.42% |
| 2023 | 1 | 4.67 | +4.54% |
| 2022 | 1 | 0.36 | +0.35% |
| 2021 | 1 | 0.15 | +0.15% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 19 Aug 2026 · 257 securities · top-10 weight = 51.1%
| Top holdings | Weight |
|---|---|
| 11.6% | |
| 8.5% | |
| 8.3% | |
| 7.7% | |
| 3.8% | |
| 2.6% | |
| 2.6% | |
| 2.1% | |
| 2.1% | |
| 1.9% |
Listing venues
ESMA register (FIRDS) and official exchange lists
C101 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 8 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2090062352
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2090062352
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · C101 · LU20900623522